» Articles » PMID: 28357642

Genome-wide Gene Expression Profiling of Tongue Squamous Cell Carcinoma by RNA-seq

Overview
Specialty Dentistry
Date 2017 Mar 31
PMID 28357642
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Tongue squamous cell carcinoma (TSCC) is significantly more malignant than other type of oral squamous cell carcinoma (OSCC). In this study, we aimed to identify specific global gene expression signatures of TSCC to investigate the more invasive behavior of the deeply infiltrating cancer.

Methods: Using RNA-seq technology, we detected gene expression of 20 TSCCs, 20 matched paratumor tissues, and 10 healthy normal mucosa tissues. Enrichment analysis of gene ontology (GO) and pathway was conducted using online tools DAVID for the dysregulated genes. Additionally, we performed the quantitative real-time RT-PCR (qRT-PCR) to validate the findings of RNA-Seq in 10 samples of TSCC, matched paratumor, and normal mucosa, respectively.

Results: We detected 252 differentially expressed genes (DEGs) between TSCC and matched paratumor tissue, including 117 up-regulated and 135 down-regulated genes. For comparison between TSCC and normal mucosa, 234 DEGS were identified, consisting of 67 up-regulated and 167 down-regulated genes. For both two comparisons, GO categories of muscle contraction (GO: 0006936), epidermis development (GO: 0008544), epithelial cell differentiation (GO: 0030855), and keratinization (GO: 0031424) were commonly enriched. Altered gene expression affected some cancer-related pathways, such as tight junction. The qRT-PCR validation showed that gene expression patterns of FOLR1, NKX3-1, TFF3, PIGR, NEFL, MMP13, and HMGA2 were fully in concordance with RNA-Seq results.

Conclusion: Findings in this study demonstrated the genetic and molecular alterations associated with TSCC, providing new clues for understanding the molecular mechanisms of TSCC pathogenesis.

Citing Articles

Transcriptomic Profile of Canine Mammary Ductal Carcinoma.

Santos D, Fernandez G, Pardini L, Pardini M, Ferrasi A Int J Mol Sci. 2023; 24(6).

PMID: 36982287 PMC: 10049542. DOI: 10.3390/ijms24065212.


Cucurbitacin B Inhibits Cell Proliferation by Regulating X-Inactive Specific Transcript Expression in Tongue Cancer.

Tao B, Wang D, Yang S, Liu Y, Wu H, Li Z Front Oncol. 2021; 11:651648.

PMID: 34295808 PMC: 8290325. DOI: 10.3389/fonc.2021.651648.


PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis.

Parzefall T, Schnoell J, Monschein L, Foki E, Liu D, Frohne A Cancers (Basel). 2021; 13(9).

PMID: 33923093 PMC: 8123332. DOI: 10.3390/cancers13092082.


Systematically Deciphering the Pharmacological Mechanism of Fructus Aurantii via Network Pharmacology.

Jin Q, Lu J, Gao R, Xu J, Pan X, Wang L Evid Based Complement Alternat Med. 2021; 2021:6236135.

PMID: 33542744 PMC: 7843179. DOI: 10.1155/2021/6236135.


Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma.

Dai Y, Lv Q, Qi T, Qu J, Ni H, Liao Y Cancer Med. 2020; 9(9):3174-3187.

PMID: 32155325 PMC: 7196066. DOI: 10.1002/cam4.2969.


References
1.
Estilo C, O-Charoenrat P, Talbot S, Socci N, Carlson D, Ghossein R . Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 2009; 9:11. PMC: 2649155. DOI: 10.1186/1471-2407-9-11. View

2.
Ward B, Dunham T, Majoros I, Baker Jr J . Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma. J Oral Maxillofac Surg. 2011; 69(9):2452-9. PMC: 3162993. DOI: 10.1016/j.joms.2010.12.041. View

3.
Zhao X, Zhang H, Jiao J, Tang D, Wu Y, Pan C . Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. J Transl Med. 2016; 14:26. PMC: 4730598. DOI: 10.1186/s12967-016-0777-0. View

4.
Ko W, Sugahara K, Sakuma T, Yen C, Liu S, Liaw G . Copy number changes of CRISP3 in oral squamous cell carcinoma. Oncol Lett. 2012; 3(1):75-81. PMC: 3362391. DOI: 10.3892/ol.2011.418. View

5.
Martin T, Jiang W . Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 2008; 1788(4):872-91. DOI: 10.1016/j.bbamem.2008.11.005. View